原著論文(英文)

2018年

  • Okamoto A, Yamasaki M, Yokota I, Mori M, Matsuda M , Yamaguchi Y , Yamakita S, Ueno H, Sawa T, Taguchi T, Hosokawa T, Amaya F. Classi cation of acute pain trajectory after breast cancer surgery identi es patients at risk for persistent pain. a prospective observational study. J Pain Res.
    accepted.
  • Kunikane H, Yokota I, Katakami N, Takeda K, Takayama K , Sawa T, Saito H, Harada M, Yokota S, Ando K, Saito Y, Ohashi Y, Eguchi K. Prospective analysis of the association between skeletal-related events and quality of life in patients with advanced lung cancer (CSP-HOR13). Oncol Lett. accepted.
  • Katayama K, Imai T, Abe Y, Nawa T, Maeda N, Nakanishi K, Wada H, Fukui K, Ito Y, Yokota I, Ohkawa K. Number of nodules but not size of hepatocellular carcinoma can predict refractoriness to transarterial chemoembolization and poor prognosis. J Clin Med Res. 2018; 10: 765-771.
  • Goto M, Sakai K, Yokota H, Kiba M, Yoshida M, Imai H, Weiland E, Yokota I, Yamada K. Diagnostic performance of initial enhancement analysis using ultra-fastdynamic contrast-enhanced MRI for breast lesions. Eur Radiol. [Epub ahead of print]
  • Kitazawa K, Wakimasu K, Kayukawa K, Yokota I, Inatomi T, Hieda O, Sotozono C, Kinoshita S. Moderately long-term safety and efficacy of repeat penetrating keratoplasty. Cornea. 2018; 37: 1255-1259.
  • Watanabe A, Nakamae T, Sakai Y, Nishida S, Abe Y, Yamada K, Yokota I, Narumoto J. The detection of white matter alterations in obsessive-compulsive disorder revealed by TRActs Constrained by UnderLying Anatomy (TRACULA). Neuropsychiatr Dis Treat. 2018; 14: 1635-1643.
  • Toyama T, Yoshimura A, Hayashi T, Kobatashi N, Saito K, Tsuneizumi M, Sawaki M, Hattori M, Nakada T, Yokota I, Iwata H. A randomized phase II study evaluating pyridoxine for the prevention of hand-foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer.
    Breast Cancer. [Epub ahead of print]
  • Yamazaki S, Numata S, Inoue T, Itatani K, Morimoto K, Ohira S, Manabe K, Yokota I, Yaku H. Impact of right ventricular volume and function evaluated using cardiovascular magnetic resonance imaging on outcomes after surgical ventricular reconstruction. Eur J Cardiothorac Surg. 2018. [Epub
    ahead of print]
  • Hagiwara N, Watanabe M, Iizuka-Ohashi M, Yokota I, Toriyama S, Sukeno M, Tomosugi M, Sowa Y, Hongo F, Mikami K, Soh J, Fujito A, Miyashita H, Morioka Y, Miki T, Ukimura O, Sakai T. Mevalonate pathway blockage enhances the efficacy of mTOR inhibitors with the activation of retinoblastoma protein in renal cell carcinoma. Cancer Lett. 2018; 431:182-189.
  • Hishiki T, Matsumoto K, Ohira M, Kamijo T, Shichino H, Kuroda T, Yoneda A, Soejima T, Nakazawa A, Takimoto T, Yokota I, Teramukai S, Takahashi H, Fukushima T, Kaneko T, Hara J, Kaneko M, Ikeda H, Tajiri T, Nakagawara A; Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG). Int J Clin Oncol. 2018.
    [Epub ahead of print]
  • Kinoshita S, Koizumi N, Ueno M, Okumura N, Imai K, Tanaka H, Yamamoto Y, Nakamura T, Inatomi T, Bush J, Toda M, Hagiya M, Yokota I, Teramukai S, Sotozono C, Hamuro J. Injection of cultured cells with ROCK inhibitor for bullous keratopathy. N Engl J Med. 2018;378:995-1003.
  • Kitagawa N, Ushigome E, Matsumoto S, Oyabu C, Ushigome H, Yokota I, Asano M, Tanaka M, Yamazaki M, Fukui M. Prognostic signi cance of home pulse pressure for progression of diabetic nephropathy: KAMOGAWA-HBP study. Hypertens Res. 2018; 41: 363-371.
  • Mizuno Y, Tsukamoto T, Kawata E, Uoshima N, Uchiyama H, Yokota I, Maegawa S, Takimoto T, Tanba K, Matsumura-Kimoto Y, Kuwahara-Ota S, Fujibayashi Y, Yamamoto-Sugitani M, Chinen Y, Shimura Y, Horiike S, Taniwaki M, Kobayashi T, Kuroda J. Chromosomal abnormality variation detected by G-banding is associated with prognosis of diffuse large B-cell lymphoma treated by R-CHOP-based therapy. Cancer Med. 2018;7:655-664.
  • Ushigome E, Oyabu C, Tanaka T, Hasegawa G, Ohnishi M, Tsunoda S, Ushigome H, Yokota I, Nakamura N, Oda Y, Asano M, Tanaka M, Yamazaki M, Fukui M. Impact of masked hypertension on diabetic nephropathy in patients with type II diabetes: a KAMOGAWA-HBP study. J Am Soc Hypertens. 2018;12:364-371.
  • Kitagawa N, Ushigome E, Matsumoto S, Oyabu C, Ushigome H, Yokota I, Asano M, Tanaka M, Yamazaki M, Fukui M. Threshold value of home pulse pressure predicting arterial stiffness in patients with type 2 diabetes: KAMOGAWA-HBP study. J Clin Hypertens. 2018;20:472-477.
  • Kaibori M, Yoshii K, Yokota I. Reply to “Relative survival instead of overall survival should be used as outcome when analyzing the effect of age after treatment of hepatocellular carcinoma”. Ann Surg. 2018 [Epub ahead of print]
  • Matsumura-Kimoto Y, Kuroda J, Kaneko H, Kamitsuji Y, Fuchida SI, Nakaya A, Shibayama H, Uoshima N, Yokota I, Uchiyama H, Yagi H, Kosugi S, Matsui T, Ishikawa J, Matsuda M, Ohta K, Iida M, Tanaka H, Kobayashi M, Wada K, Shimazaki C, Nomura S, Imada K, Hino M, Matsumura I, Kanakura Y, Takaori-Kondo A; Kansai Myeloma Forum Investigators. Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma Forum. Int J Hematol. 2018; 107: 541-550.
  • Ushigome E, Matsumoto S, Oyabu C, Kitagawa N, Tanaka T, Hasegawa G, Ohnishi M, Tsunoda S, Ushigome H, Yokota I, Nakamura N, Oda Y, Asano M, Tanaka M, Yamazaki M, Fukui M. Prognostic signi cance of day-by-day variability of home blood pressure on progression to macroalbuminuria in patients with diabetes. J Hypertens. 2018; 36: 1068-1075.
  • Kawamura T, Takeuchi Y, Asai S, Yokota I, Akamine E, Kato M, Akamatsu T, Tada K, Komeda Y, Iwatate M, Kawakami K, Nishikawa M, Watanabe D, Yamauchi A, Fukata N, Shimatani M, Ooi M, Fujita K, Sano Y, Kashida H, Hirose S, Iwagami H, Uedo N, Teramukai S, Tanaka K. A comparison of the resection rate for cold and hot snare polypectomy for 4-9 mm colorectal polyps: a multicentre randomised controlled trial (CRESCENT study). Gut. 2018; 67: 1950-1957.
  • Yamada K, Shiraishi H, Oki E, Ishige M, Fukao T, Hamada Y, Sakai N, Ochi F, Watanabe A, Kawakami S, Kuzume K, Watanabe K, Sameshima K, Nakamagoe K, Tamaoka A, Asahina N, Yokoshiki S, Miyakoshi T, Ono K, Oba K, Isoe T, Hayashi H, Yamaguchi S, Sato N. Open-label clinical trial of bezafibrate treatment in patients with fatty acid oxidation disorders in Japan. Molecular Genetics and Metabolism Reports. 2018;15:55-63.
  • Umazume T, Yamada T, Yamada S, Ishikawa S, Furuta I, Iwano H, Murai D, Hayashi T, Okada K, Morikawa M, Yamada T, Ono K, Tsutsui H, Minakami H. Morphofunctional cardiac changes in pregnant women: associations with biomarkers. Open Heart. 2018;5:e000850.
  • Tokairin K, Kazumata K, Uchino H, Ito M, Ono K, Tatezawa R, Shindo T, Kawabori M, Nakayama N, Houkin K. Postoperative Intracerebral Hemorrhage After Combined Revascularization Surgery in Moyamoya Disease: Profiles and Clinical Associations. World Neurosurgery. 2018.
  • Omori K, Nomoto H, Nakamura A, Takase T, Cho KY, Ono K, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H. Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea. Journal of Diabetes Investigation. 2018.
  • Oita M, Miyoshi H, Ono K, Nakamura A, Cho KY, Nomoto H, Yamamoto K, Omori K, Manda N, Kurihara Y, Aoki S, Atsumi T. Satisfaction and efficacy of switching from daily dipeptidyl peptidase-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes-Randomized controlled study. Endocr J. 2018;65:141-50.
  • Nishioka K, Prayongrat A, Ono K, Onodera S, Hashimoto T, Katoh N, Inoue T, Kinoshita R, Yasuda K, Mori T, Onimaru R, Shirato H, Shimizu S. Prospective study to evaluate the safety of the world-first spot-scanning dedicated, small 360-degree gantry, synchrotron-based proton beam therapy system. J Radiat Res. 2018;59:i63-i71.
  • Kudo D, Hayakawa M, Ono K, Yamakawa K. Impact of non-anticoagulant therapy on patients with sepsis-induced disseminated intravascular coagulation: A multicenter, case-control study. Thrombosis Research. 2018;163:22-9.
  • Kakutani N, Fukushima A, Yokota T, Katayama T, Nambu H, Shirakawa R, Maekawa S, Abe T, Takada S, Furihata T, Ono K, Okita K, Kinugawa S, Anzai T. Impact of High Respiratory Exchange Ratio During Submaximal Exercise on Adverse Clinical Outcome in Heart Failure. Circulation Journal. 2018;82:2753-60.
  • Honda H, Ono K, Akizawa T, Nitta K, Hishida A. Association of adiposity with hemoglobin levels in patients with chronic kidney disease not on dialysis. Clin Exp Nephrol. 2018;22:638-46.
  • Hayakawa M, Ono K. A summary of the Japan septic disseminated intravascular coagulation study. Acute Med Surg. 2018;5:123-8.

2017年

  • Kan H, Arai Y, Kobayashi M, Nakagawa S, Inoue H, Hino M, Komaki S, Ikoma K, Ueshima K, Fujiwara H, Yokota I, Kubo T. Fixed-exion view X-ray of the knee superior in detection and follow-up of knee osteoarthritis. Medicine. 2017. 96:e9126.
  • Kaibori M, Yoshii K, Yokota I, Hasegawa K, Nagashima F, Kubo S, Kon M, Izumi N, Kadoya M, Kudo M, Kumada T, Sakamoto M, Nakashima O, Matsuyama Y, Takayama T, Kokudo N; Liver Cancer Study Group of Japan. Impact of advanced age on survival in patients undergoing resection of hepatocellular carcinoma: report of a Japanese nationwide survey. Ann Surg. 2017. [Epub ahead of print]
  • Oyabu C, Ushigome E, Matsumoto S, Tanaka T, Hasegawa G, Nakamura N, Ohnishi M, Tsunoda S, Ushigome H, Yokota I, Tanaka M, Asano M, Yamazaki M, Fukui M. Maximum home blood pressure is a useful indicator of diabetic nephropathy in patients with type 2 diabetes mellitus: KAMOGAWA-HBP study. Diab Vasc Dis Res. 2017; 14: 477-484.
  • Kitazawa K, Kayukawa K,Wakimasu K, Yokota I, Inatomi T, Hieda O, Mori K, Sotozono C, Kinoshita S. Predictive clinical factors of cystoid macular edema in patients with Descemet’s stripping automated endothelial keratoplasty. Sci Rep. 2017; 7: 7412.
  • Masuda N, Lee SJ, Ohtani S, Im YH, Lee ES, Yokota I, Kuroi K, Im SA, Park BW, Kim SB, Yanagita Y, Ohno S, Takao S, Aogi K, Iwata H, Jeong J, Kim A, Park KH, Sasano H, Ohashi Y, Toi M. Adjuvant capecitabine for breast cancer after preoperative chemotherapy. N Engl J Med. 2017;376:2147-2159.
  • Shimoyama H, Isotani S, China T, Nagata M, Yokota I, Kitamura K, Wakumoto Y, Ide H, Muto S, Tujimura A, Yamaguchi R, Horie S. Automated renal cortical volume measurement for assessment of renal function in patients undergoing radical nephrectomy. Clin Exp Nephrol. 2017;21:1124-1130.
  • Sowa Y, Yokota I, Itsukage S, Nakatsukasa K, Sakaguchi K, Taguchi T, Numajiri T. Evaluation of the severity of capsular contracture using elastography after breast implant reconstruction. Clin Hemorheol Microcirc. 2017;66:1-6.
  • Harada K, Ochi K, Taguchi T, Nakamura T, Kanazawa M, Yoshida N, Neriya H, Okagaki M, Nishida N, Takishita Y, Yamamoto Y, Wada S, Kuwahata M, Yokota I, Sekido K, Higashi A. Validity of the short nutritional assessment questionnaire for Japanese patients with cancer undergoing outpatient chemotherapy. J Med Invest. 2017;64:117-121.
  • Yamaue H, Shimizu A, Hagiwara Y, Sho M, Yanagimoto H, Nakamori S, Ueno H, Ishii H, Kitano M, Sugimori K, Maguchi H, Ohkawa S, Imaoka H, Hashimoto D, Ueda K, Nebiki H, Nagakawa T, Isayama H, Yokota I, Ohashi Y, Shirasaka T. Multicenter, randomized, open-label phase II study comparing S-1 alternate-day oral therapy with the standard daily regimen as a rst-line treatment in patients with unresectable advanced pancreatic cancer. Cancer Chemother Pharmacol. 2017;79:813-823.
  • Taniguchi Y, Kitamura A, Murayama H, Amano H, Shinozaki T, Yokota I, Seino S, Nofuji Y, Nishi M, Yokoyama Y, Matsuyama Y, Fujuwara Y, Shinkai S. Mini-mental state examination score trajectories and incident disabling dementia among community-dwelling older Japanese. Geriatr Gerontol Int. 2017;17:1928-1935.
  • Kawamura T, Wada H, Sakiyama N, Ueda Y, Shirakawa A, Okada Y, Sanada K, Nakase K, Mandai K, Suzuki A, Kamaguchi M, Morita A, Nishioji K, Tanaka K, Mochizuki N, Uno K, Yokota I, Kobayashi M, Yasuda K. Examination time as a quality indicator of screening upper gastrointestinal endoscopy for asymptomatic examinees. Dig Endosc. 2017;29:569-575.
  • Taniguchi Y, Kitamura A, Seino S, Murayama H, Amano H, Nofuji Y, Nishi M, Yokoyama Y, Shinozaki T, Yokota I, Matsuyama Y, Fujiwara Y, Shinkai S. Gait performance trajectories and incident disabling dementia among community-dwelling older Japanese. J Am Med Dir Assoc. 2017;18:192.e13-192.e20.
  • Ushigome E, Matsumoto S, Oyabu C, Ushigome H, Yokota I, Hasegawa G, Nakamura N, Tanaka M, Yamazaki M, Fukui M. Olmesartan with azelnidipine versus with trichlormethiazide on home blood pressure variability in patients with type II diabetes mellitus. J Am Soc Hypertens. 2017: 11; 140-147.
  • Kitazawa K, Kayukawa K, Wakimasu K, Yokota I, Inatomi T, Hieda O, Mori K, Sotozono C, Kinoshita S. Cystoid macular edema after Descemet ’s stripping automated endothelial keratoplasty. Ophthalmology. 2017;124:572-3.
  • Matsuda M, Oh-hashi K, Yokota I, Sawa T, Amaya F. Acquired exchange protein directly activated by cyclic adenosine monophosphate activity induced by p38MAPK in primary afferent neurons contributes to sustaining postincisional nociception. Anesthesiology. 2017;126:150-162.
  • Yanishi K, Nakamura T, Nakanishi N, Yokota I, Zen K, Yamano T, Shiraishi H, Shirayama T, Shiraishi J, Sawada T, Kohno Y, Kitamura M, Furukawa K, Matoba S. A simple risk strati cation model for ST-elevation myocardial infarction (STEMI) from the combination of blood examination variables: acute myocardial infarction-Kyoto multi-center risk study group. PLoS One. 2016;11:e0166391.
  • Nagao M, Yamamoto M, Matsumura Y, Yokota I, Takakura S, Teramukai S, Ichiyama S. Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis. Infection. 2017; 45:83-91.
  • Kanezaki S, Nakamura S, Nakamura M, Yokota I, Matsushita T. Curtain osteophyte is one of the risk factors for poor outcome of rotational acetabular osteotomy. Int Orthop. 2017;41:265-70.
  • Tokairin K, Osanai T, Abumiya T, Kazumata K, Ono K, Houkin K. Regional transarterial hypothermic infusion in combination with endovascular thrombectomy in acute ischaemic stroke with cerebral main arterial occlusion: protocol to investigate safety of the clinical trial. BMJ Open. 2017;7:e016502.
  • Takauji S, Hayakawa M, Ono K, Makise H. Respiratory extracorporeal membrane oxygenation for severe sepsis and septic shock in adults: a propensity score analysis in a multicenter retrospective observational study. Acute Med Surg. 2017;4:408-17.
  • Nomoto H, Miyoshi H, Sugawara H, Ono K, Yanagiya S, Oita M, Nakamura A, Atsumi T. A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin. Diabetol Metab Syndr. 2017;9:54.
  • Nakamura M, Ishiguro A, Muranaka T, Fukushima H, Yuki S, Ono K, Murai T, Matsuda C, Oba A, Itaya K, Sone T, Yagisawa M, Koike Y, Endo A, Tsukuda Y, Ono Y, Kudo T, Nagasaka A, Nishikawa S, Komatsu Y. A Prospective Observational Study on Effect of Short-Term Periodic Steroid Premedication on Bone Metabolism in Gastrointestinal Cancer (ESPRESSO-01). Oncologist. 2017;22:592-600.
  • Muranaka T, Komatsu Y, Yagisawa M, Sawada K, Harada K, Kawamoto Y, Nakatsumi H, Yuki S, Ono K, Kawahata S, Kobayashi Y, Sogabe S, Miyagishima T, Hatanaka K, Sasaki T, Dazai M, Iwanaga I, Ishiguro A, Nakamura M, Sakamoto N, Sakata Y. Feasibility Study of Bolus 5-Fluorouracil+L-Leucovorin as Salvage Line Chemotherapy for Oral Fluorouracil-Resistant Unresectable Gastric Cancer: Hokkaido Gastrointestinal Cancer Study Group Study HGCSG1502. Journal of Clinical Trials. 2017;07(06).
  • Murai D, Yamada S, Hayashi T, Okada K, Nishino H, Nakabachi M, Yokoyama S, Abe A, Ichikawa A, Ono K, Kaga S, Iwano H, Mikami T, Tsutsui H. Relationships of left ventricular strain and strain rate to wall stress and their afterload dependency. Heart Vessels. 2017;32:574-83.
  • Kitao N, Miyoshi H, Furumoto T, Ono K, Nomoto H, Miya A, Yamamoto C, Inoue A, Tsuchida K, Manda N, Kurihara Y, Aoki S, Nakamura A, Atsumi T, Group SS. The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3). Cardiovasc Diabetol. 2017;16:125.
  • Kinoshita T, Yamakawa K, Matsuda H, Yoshikawa Y, Wada D, Hamasaki T, Ono K, Nakamori Y, Fujimi S. The Survival Benefit of a Novel Trauma Workflow that Includes Immediate Whole-body Computed Tomography, Surgery, and Interventional Radiology, All in One Trauma Resuscitation Room: A Retrospective Historical Control Study. Ann Surg. 2017.
  • Kato S, Kuwatani M, Sugiura R, Sano I, Kawakubo K, Ono K, Sakamoto N. Effect of endoscopic transpapillary biliary drainage with/without endoscopic sphincterotomy on post-endoscopic retrograde cholangiopancreatography pancreatitis in patients with biliary stricture (E-BEST): a protocol for a multicentre randomised controlled trial. BMJ Open. 2017;7:e017160.
  • Demizu Y, Mizumoto M, Onoe T, Nakamura N, Kikuchi Y, Shibata T, Okimoto T, Sakurai H, Akimoto T, Ono K, Daimon T, Murayama S. Proton beam therapy for bone sarcomas of the skull base and spine: A retrospective nationwide multicenter study in Japan. Cancer Sci. 2017;108:972-7.

2016年以前

  • Minamisawa A, Narumoto J, Yokota I, Fukui K. Evaluation of factors associated with psychiatric patient dropout at a university outpatient clinic in Japan. Patient Prefer Adherence. 2016; 10: 1903-11.
  • Kitazawa K, Yokota I, Sotozono C, Kinoshita S. Measurement of corneal endothelial surface area using anterior segment optical coherence tomography in normal subjects. Cornea. 2016; 35: 1229-33.
  • Tatekawa S, Kohno A, Ozeki K, Watamoto K, Ueda N, Yamaguchi Y, Kobayashi T, Yokota I, Teramukai S, Taniwaki M, Kuroda J, Morishita Y. A novel diagnostic and prognostic biomarker panel for endothelial cell damage-related complications in allogeneic transplantation. Biol Blood Marrow Transplant. 2016; 22: 1573-81.
  • Taniguchi Y, Fujiwara Y, Murayama H, Yokota I, Matsuo E, Seino S, Nofuji Y, Nishi M, Matsuyama Y, Shinkai S. Prospective study of trajectories of physical performance and mortality among community-dwelling older Japanese. J Gerontol A Biol Sci Med Sci. 2016; 71:1492-9.
  • Tsuji Y, Noto Y, Shiga K, Yokota I, Nakagawa M, Mizuno T. Does hand dominance affect peripheral nerve excitability? Clin Neurophysiol. 2016; 127: 1921-2.
  • Kobayashi T, Kuroda J, Yokota I, Tanba K, Fujino T, Kuwahara S, Isa R, Yamaguchi J, Kawata E, Akaogi T, Uchiyama H, Kaneko H, Uoshima N, Kobayashi Y, Teramukai S, Taniwaki M. The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era. Blood Cancer J. 2016; 6: e383;
  • Kadoya A, Ogawa G, Kawakami S, Yokota I, Hatanaka Y, Uchibori A, Chiba A, Sonoo M. The correlation between the change of distal motor latency of the median nerve and the abundant A-waves in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry. 2016; 87: 444-6.
  • Yamamoto C, Miyoshi H, Ono K, Sugawara H, Kameda R, Ichiyama M, Yamamoto K, Nomoto H, Nakamura A, Atsumi T. Ipragliflozin effectively reduced visceral fat in Japanese patients with type 2 diabetes under adequate diet therapy. Endocr J. 2016;63:589-96.
  • Koyanagawa N, Miyoshi H, Ono K, Nakamura A, Cho KY, Yamamoto K, Takano Y, Dan-Noura M, Atsumi T. Comparative effects of vildagliptin and sitagliptin determined by continuous glucose monitoring in patients with type 2 diabetes mellitus. Endocr J. 2016;63:747-53.
  • Ishiguro N, Oyamada R, Nasuhara Y, Yamada T, Miyamoto T, Imai S, Akizawa K, Fukumoto T, Iwasaki S, Iijima H, Ono K. Three-day regimen of oseltamivir for postexposure prophylaxis of influenza in wards. J Hosp Infect. 2016;94:150-3.
  • Hayakawa M, Yamakawa K, Saito S, Uchino S, Kudo D, Iizuka Y, Sanui M, Takimoto K, Mayumi T, Ono K, Japan Septic Disseminated Intravascular Coagulation study g. Recombinant human soluble thrombomodulin and mortality in sepsis-induced disseminated intravascular coagulation. A multicentre retrospective study. Thromb Haemost. 2016;115:1157-66.
  • Hayakawa M, Kudo D, Saito S, Uchino S, Yamakawa K, Iizuka Y, Sanui M, Takimoto K, Mayumi T, Ono K, Azuhata T, Ito F, Yoshihiro S, Hayakawa K, Nakashima T, Ogura T, Noda E, Nakamura Y, Sekine R, Yoshikawa Y, Sekino M, Ueno K, Okuda Y, Watanabe M, Tampo A, Saito N, Kitai Y, Takahashi H, Kobayashi I, Kondo Y, Matsunaga W, Nachi S, Miike T, Takahashi H, Takauji S, Umakoshi K, Todaka T, Kodaira H, Andoh K, Kasai T, Iwashita Y, Arai H, Murata M, Yamane M, Shiga K, Hori N. Antithrombin Supplementation and Mortality in Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study. Shock. 2016;46:623-31.
  • Isotani S, Shimoyama H, Yokota I, China T, Hisasue SI, Ide H, Muto S, Yamaguchi R, Ukimura O, Horie S. Feasibility and accuracy of computational robot-assisted partial nephrectomy planning by virtual partial nephrectomy analysis. Int J Urol. 2015; 22:439-46.
  • Isotani S, Shimoyama H, Yokota I, Noma Y, Kitamura K, China T, Saito K, Hisasue SI, Ide H, Muto S, Yamaguchi R, Ukimura O, Gill IS, Horie S. Novel prediction model of renal function after nephrectomy from automated renal volumetry with preoperative multidetector computed tomography (MDCT). Clin Exp Nephrol. 2015; 19: 974-81.
  • Yasuda S, Atsumi T, Shimamura S, Ono K, Hiromura K, Sada K, Mori M, Takei S, Kawaguchi Y, Tamura N, Takasaki Y. Surveillance for the use of mycophenolate mofetil for adult patients with lupus nephritis in Japan. Mod Rheumatol. 2015;25:854-7.
  • Ukawa S, Tamakoshi A, Ono K. A randomized controlled trial of a long-term functioning improvement tool home visit program for frail older Japanese people. Int J Geriatr Psychiatry. 2015;30:887-8.
  • Asakawa N, Sakakibara M, Noguchi K, Kamiya K, Yamada S, Yoshitani T, Ono K, Oba K, Tsutsui H. Adaptive servo-ventilation has more favorable acute effects on hemodynamics than continuous positive airway pressure in patients with heart failure. Int Heart J. 2015;56:527-32.
  • Kitamura K, Muto S, Yokota I, Hoshimoto K, Kaminaga T, Noguchi T, Sugiura S, Ide H, Yamaguchi R, Furui S, Horie S. Feasibility of multiparametric prostate magnetic resonance imaging in the detection of cancer distribution: histopathological correlation with prostatectomy specimens. Prostate Int. 2014; 2:188-95.
  • Aihara T, Yokota I, Hozumi Y, Aogi K, Iwata H, Tamura M, Fukuuchi A, Makino H, Kim R, Andoh M, Tsugawa K, Ohno S, Yamaguchi T, Ohashi Y, Watanabe T, Takatsuka Y, Mukai H. Anastrozole versus tamoxifen as adjuvant therapy for Japanese postmenopausal patients with hormone-responsive breast cancer: efficacy results of long-term follow-up data from the N-SAS BC 03 trial. Breast Cancer Res Treat. 2014; 148: 337-43.
  • Katakami N, Kunikane H, Takeda K, Takayama K, Sawa T, Saito H, Harada M, Yokota S, Ando K, Saito Y, Yokota I, Ohashi Y, Eguchi K. Prospective Study on the incidence of bone metastasis (BM) and skeletal-related events (SREs) in Patients (pts) with stage IIIB and IV lung cancer-CSP-HOR 13. J Thorac Oncol. 2014; 9:231-8.

原著論文(和文)

  • 加藤 佑佳, 松田 万祐理, 澤田 親男, 原田 倫治, 山田 美和, 加嶋 晶子, 柏 由紀子, 細井 哲, 横田 勲, 手良向 聡, 成本 迅.高齢統合失調症患者を対象とした抗精神病薬と脂質異常症薬に関する医療同意能力の比較およびデシジョン・エイドによる介入の試み.精神医学 2018;60:75-83.
  • 横田 勲. 再現性…相関係数とBland-Altman plot. Coronary Intervention. 2017;13: 47-52.
  • 横田 勲, 手良向聡. メタアナリシスのピットフォール. 循環器内科. 2016; 79: 267-70.
  • 中村 葉, 稗田 牧, 山村 陽, 脇舛 耕一, 横田 勲, 木下 茂. Laser in situ keratomileusisとtrans-epithelial photorefractive keratectomyの術後7年の経過比較. 日本眼科学会雑誌. 2016; 120: 487-93.

発表

生物統計学系の学会、セミナー

  • Yokota I. United milestones survival analysis in single-arm trial. 2nd Paci c Rim Cancer Biostatistics Workshop, Kanazawa, Japan, August 13, 2017.
  • Yokota I, Teramukai S. United milestones survival analysis in single-arm trial. 38th Annual Conference of the International Society for Clinical Biostatistics, Vigo, Spain, July 11, 2017. Abstract T31.
  • Yokota I. Comparing the tests for a survival curve at a xed time point in single arm study. ENAR 2017 Spring meeting, Washington DC, Canada, March 12-15, 2017. Posters 8j.
  • Yokota I, Kashiwabara K, Sakamaki K, Teramukai S. Comparison of sequential clinical trial designs with time-to-event outcomes in small populations. XXVIIIth International Biometric Conference, Victoria, BC, Canada, July 10-15, 2016. Abstract 2464724.
  • Yokota I, Matsuyama Y. Dynamic prediction for repeated events data based on landmark model using dynamic pseudo observations. 36th Annual Conference of the International Society for Clinical Biostatistics, Utrecht, The Netherlands, August 23-27, 2015. Abstract P07-5.
  • Yokota I, Matsuyama Y, Ohashi Y. Extension on a landmarking model using a fractional polynomial function for dynamic prediction. 34th Annual Conference of the International Society for Clinical Biostatistics, Munich, Germany, August 25-29, 2013. Abstract P136.
  • Yokota I, Matsuyama Y, Ohashi Y. Comparison of the tests for interval-censored data with differential assessment times. XXVIth International Biometric Conference, Kobe, Japan, August 28, 2012. Abstract 338.
  • Yokota I, Matsuyama Y, Ohashi Y. Simulation studies on the analysis of interval-censored survival data with differential assessment times. 2012 Joint Statistical Meetings, San Diego, CA, July 30, 2012. Abstract 253.

 

  • 横田 勲. 生存時間型エンドポイントをおいた単群試験の計画. 研究集会 「臨床研究・疫学研究の統計学的方法論の発展とその実践」, 静岡, 2018/5/11.
  • 横田 勲, 松山 裕. 動的予測を用いた代替エンドポイントの評価. 2015 年度 日本計量生物学会年会, 京都, 2015/3/12.
  • 横田 勲. 群間で打ち切り確率の異なる区間打ち切り生存時間データに対する解析手法の検討. 第6回Biostatistics Network, 福岡, 2011/8/3.

 

臨床系の学会、セミナー

  • 横田 勲. 生存時間解析:疾病発生予測モデルの構築にむけて. 北海道大学病院 臨床研究開発センター, 2018/6/28.
  • 横田 勲. 臨床研究における統計解析のポイント. 第33回日本環境感染学会総会・学術集会, 東京, 2018/2/24.
  • 横田 勲. 中間解析、中間モニタリングに用いられる統計手法. ARO協議会 生物統計セミナー, 東京, 2018/2/3.
  • 横田 勲. 観察研究データの解析~P値からの脱却~. 京都第一赤十字病院, 2018/1/18.
  • 横田 勲. 中間解析、中間モニタリングに用いられる統計手法. ARO協議会 第5回学術集会, 名古屋, 2017/9/25.